Conor McNamara
Stock Analyst at RBC Capital
(0.75)
# 3,657
Out of 4,829 analysts
122
Total ratings
20%
Success rate
-22.01%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintains: Sector Perform | $72 → $63 | $53.90 | +16.88% | 9 | May 8, 2025 | |
| HOLX Hologic | Maintains: Sector Perform | $75 → $70 | $58.81 | +19.03% | 10 | May 2, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $409 → $392 | $256.68 | +52.72% | 11 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $409 → $392 | $252.64 | +55.16% | 11 | May 2, 2025 | |
| RGEN Repligen | Maintains: Outperform | $202 → $189 | $133.72 | +41.34% | 11 | Apr 30, 2025 | |
| AVTR Avantor | Maintains: Outperform | $24 → $20 | $13.00 | +53.85% | 7 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $651 → $637 | $432.59 | +47.25% | 14 | Apr 24, 2025 | |
| DHR Danaher | Reiterates: Outperform | $250 | $200.83 | +24.48% | 9 | Apr 23, 2025 | |
| ILMN Illumina | Maintains: Outperform | $128 → $112 | $81.57 | +37.31% | 15 | Apr 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $7 → $4 | $1.43 | +179.72% | 3 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $157.29 | +59.58% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $37.42 | +63.01% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $13 | $2.12 | +513.21% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $3.19 | +119.78% | 4 | Aug 7, 2024 |
Bio-Techne
May 8, 2025
Maintains: Sector Perform
Price Target: $72 → $63
Current: $53.90
Upside: +16.88%
Hologic
May 2, 2025
Maintains: Sector Perform
Price Target: $75 → $70
Current: $58.81
Upside: +19.03%
Bio-Rad Laboratories
May 2, 2025
Maintains: Outperform
Price Target: $409 → $392
Current: $256.68
Upside: +52.72%
Bio-Rad Laboratories
May 2, 2025
Maintains: Outperform
Price Target: $409 → $392
Current: $252.64
Upside: +55.16%
Repligen
Apr 30, 2025
Maintains: Outperform
Price Target: $202 → $189
Current: $133.72
Upside: +41.34%
Avantor
Apr 28, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $13.00
Upside: +53.85%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $432.59
Upside: +47.25%
Danaher
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $200.83
Upside: +24.48%
Illumina
Apr 8, 2025
Maintains: Outperform
Price Target: $128 → $112
Current: $81.57
Upside: +37.31%
OmniAb
Mar 27, 2025
Maintains: Outperform
Price Target: $7 → $4
Current: $1.43
Upside: +179.72%
Mar 13, 2025
Initiates: Outperform
Price Target: $251
Current: $157.29
Upside: +59.58%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $37.42
Upside: +63.01%
Nov 8, 2024
Maintains: Outperform
Price Target: $17 → $13
Current: $2.12
Upside: +513.21%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $3.19
Upside: +119.78%